HLA-A and COVID-19: Toyoshima et al. showed that HLA-A*11:01 was defensive against SARS-CoV-2 susceptibility and COVID-19 fatality when compared to the global database for allele rate, infection, or death [71], which were inconsistent with research that compared allele incidence and effect at an individual level [45,46,47].